Announcing: Chiesi Farmaceutici S.p.A. has acquired Amryt Pharma. View the press release to learn more
Find articles, press releases, and the latest developments in rare disease from our Thought Leadership Series.
Join our rare community
17/08/2023
BOSTON, August 17, 2023 – Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people affected by rare diseases, announced today that the U.S. Food and Drug Administration (FDA) has approved ELFABRIO (pegunigalsidase alfa-iwxj) in...
Discover treatments that are helping to change the rare disease landscape.
Discover innovative treatments that are helping to change the rare disease landscape.
Explore rare disease therapies under development.
Explore novel therapies under development.
From research to results, see how we’re committed to helping you help your patients.
Find support, advocacy, and what we value most—a caring community.
Facebook
Instagram
LinkedIn
X
YouTube